Explore
High-Risk Localized and Locally Advanced Prostate Cancer
Kouji Izumi (editor)
2023
0 Ungluers have
Faved this Work
Login to Fave
Around 20%–30% of nonmetastatic prostate cancer patients have high-risk localized disease. The best treatment for high-risk localized disease is still unclear, and the reliability of the definition of “high-risk” may need to be validated first. Although recent advances in radiotherapy for prostate cancer have yielded excellent long-term results, even in high-risk localized disease, there are no studies directly comparing it with local treatment options, such as prostatectomy. To address current challenges in high-risk localized and locally advanced prostate cancer, 12 original and 3 review articles covering aspects from basic research to clinical trials are published in this Special Issue.
This book is included in DOAB.
Why read this book? Have your say.
You must be logged in to comment.
Rights Information
Are you the author or publisher of this work? If so, you can claim it as yours by registering as an Unglue.it rights holder.Downloads
This work has been downloaded 23 times via unglue.it ebook links.
- 23 - pdf (CC BY) at Unglue.it.
Keywords
-  
- Biochemical engineering
- Biotechnology
- brachytherapy
- hormonal therapy
- imaging modality
- local invasion
- lymph node dissection
- neoadjuvant/adjuvant therapy
- oligometastasis
- Quality of life
- radical prostatectomy
- Technology, engineering, agriculture
- Technology: general issues
Links
DOI: 10.3390/books978-3-0365-8169-9Editions